Notice ID: fba2112d7da54dc49033b9adbe509953SolicitationArchived
Marburg virus (MARV) and Sudan virus (SUDV) Vaccines
Archived on September 11, 2025. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 2:00 PM EDT
- Posted
- July 31, 2025
- Notice type
- Solicitation
- Set-aside
- No Set aside used
- NAICS
- 541714: Research and Development in Biotechnology (except Nanobiotechnology)
- Agency
- Department of Health and Human ServicesOFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE
Notice details
- Office
- BARDA - ASPR / DAAPPO / BARDA DCMA
- Place of performance
- Washington
- Last updated
- Nov 10, 2026
- First published
- Last updated on SAM.gov
Identifiers
- Solicitation number
- 75A50125R00006
- Notice ID
- fba2112d7da54dc49033b9adbe509953
Description
The 2014 Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Strategy and Implementation Plan identifies Ebola virus and Marburg virus as high-priority threats as determined by the Department of Homeland Security to present a material threat to national security. Strategies to mitigate the threat of Ebola virus and Marburg virus include the development of vaccines suitable for protection against Ebola and Marburg virus disease respectively. BARDA is seeking vaccines that can be safely and effectively used for the U.S. civilian population in individuals with an elevated risk of exposure to Sudan virus (SUDV) and Marburg virus (MARV). This acquisition will allow BARDA to invest Project BioShield funds for the advanced development, US Food and Drug Administration (FDA) licensure, procurement, shipping, and vendor managed inventory (VMI) storage of MARV and SUDV monovalent vaccines.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Contracting Officer
Primary Contact
Yifan Yang
Secondary Contact
Greg Smith
Documents
Lifecycle
- 5Version 5PresolicitationArchived
Marburg virus (MARV) and Sudan virus (SUDV) Vaccines
- 2Version 2SolicitationArchived
Type changed from Presolicitation to Solicitation
Marburg virus (MARV) and Sudan virus (SUDV) Vaccines
- 3Version 3SolicitationArchived
Marburg virus (MARV) and Sudan virus (SUDV) Vaccines
- 7Version 7SolicitationArchivedCurrent
Marburg virus (MARV) and Sudan virus (SUDV) Vaccines
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
75A50125R00006
Archive Date
Sep 11, 2025